Is COMT a Susceptibility Gene for Schizophrenia?
- 19 March 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 33 (3) , 635-641
- https://doi.org/10.1093/schbul/sbm019
Abstract
Catechol-O-methyl transferase (COMT) is a catabolic enzyme involved in the degradation of a number of bioactive molecules; of principal interest to psychiatry, these include dopamine. The enzyme is encoded by the COMT gene. COMT is located (along with 47 other genes) in a fragment of chromosome 22q11 which when deleted results in a complex syndrome, the psychiatric manifestations of which include schizophrenia and other psychoses. These 2 observations have placed COMT near the top of a rather long list of plausible candidate genes for schizophrenia. The ability to test the hypothesis that COMT might be a susceptibility gene for schizophrenia has been simplified in principle by the existence of a valine-to-methionine (Val/Met) polymorphism which results respectively in high and low activity forms of the enzyme. Given the unequivocal effect of this polymorphism on the function of COMT, and the evidence for a critical role for dopamine in the pathophysiology and treatment of psychosis, there are strong prior expectations that Val/Met influences susceptibility to schizophrenia as well as other psychiatric phenotypes. Indeed the Val/Met polymorphism has become the most widely studied polymorphism in psychiatry. In this review, we consider the evidence for and against the involvement of COMT in schizophrenia. The current data allow us to virtually exclude a simple relationship between schizophrenia and the Val/Met variant previously thought to dominate COMT function. However, recent data suggest a more complex pattern of genetic regulation of COMT function beyond that attributable to the Val/Met locus. Moreover, it is also clear that there is a complex nonlinear relationship between dopamine availability and brain function. These 2 factors, allied to phenotypic complexity within schizophrenia, make it difficult to draw strong conclusions regarding COMT in schizophrenia. Nevertheless, emerging research that takes greater account of all these levels of complexity is beginning to provide tantalizing, but far from definitive, support for the view that COMT influences susceptibility to at least some forms of psychosis.Keywords
This publication has 71 references indexed in Scilit:
- Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: SchizophreniaAmerican Journal of Human Genetics, 2003
- A Haplotype Implicated in Schizophrenia Susceptibility Is Associated with Reduced COMT Expression in Human BrainAmerican Journal of Human Genetics, 2003
- Association between Val108/158met polymorphism of theCOMTgene and schizophreniaAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2003
- Catechol O -methyltransferase val
158
-met genotype and individual variation in the brain response to amphetamineProceedings of the National Academy of Sciences, 2003
- Association Between a Functional CatecholO-Methyltransferase Gene Polymorphism and Schizophrenia: Meta-Analysis of Case-Control and Family-Based StudiesAmerican Journal of Psychiatry, 2003
- A Highly Significant Association between a COMT Haplotype and SchizophreniaAmerican Journal of Human Genetics, 2002
- Schizophrenia and functional polymorphisms in the MAOA and COMT genes: No evidence for association or epistasisAmerican Journal of Medical Genetics, 2002
- Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophreniaMolecular Psychiatry, 2002
- Bipolar spectrum disorders in patients diagnosed with velo-cardio- facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?American Journal of Psychiatry, 1996
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996